Akorn Artificial Tears Eye Drops Recalled for Manufacturing Quality Deviations
Akorn, Inc. is voluntarily recalling 967,075 bottles of Artificial Tears Solution eye drops nationwide due to manufacturing process deviations identified during quality inspections.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall for CGMP deviations with no reported illnesses, injuries, or product defects identified. The recall is voluntary and precautionary in nature, fitting the rubric criterion for 'voluntary precautionary recalls' at the Moderate level.
Plain-English summary
Akorn, Inc. is voluntarily recalling 967,075 bottles of Artificial Tears Solution (Polyvinyl Alcohol 1.4%, 15 mL per bottle) distributed nationwide in the United States. The product was manufactured by Akorn, Inc., Lake Forest, Illinois (NDC 17478-060-12).
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during quality control inspections. CGMP deviations indicate that manufacturing processes did not meet FDA standards for product safety and efficacy. The specific details of these deviations have not been publicly disclosed.
Multiple lot numbers are affected, with expiration dates ranging from October 2022 through August 2023. This is a voluntary recall initiated by the firm.
The recalled product
- Product
- Artificial Tears Solution, Lubricant Eye Drops, Polyvinyl Alcohol 1.4%, 15 mL (0.5 fl. oz.) per bottle, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-060-12
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Eye Drops
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 0L44A
- 0L52A
- 0L51A
- 0L77A
- 0L75A
- EXP 10/31/2022
- 0M02A
- 0M01A
- EXP 11/30/2022
- 1C81A
- EXP 2/28/2023
- 1D02A
- 1D03A
- EXP 3/31/2023
- 1E10A
- 1E08A
- 1E23A
- 1E26A
- 1E25A
- 1E27A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27